Navigation Links
Trial success for diabetic nerve therapy

alled ZFP TFTM to poke life into the patient's own genes and produce a growth factor that has a role in nerve protection and regeneration.

"As the data in the paper demonstrate, we have had some striking success."

The US clinical trials ?carried out by Professor Tomlinson's collaborators at biotech firm Sangamo BioSciences Inc ?have also been encouraging with the only adverse event reported being mild injection-site reaction in four of the 12 diabetic patients tested, all of which resolved quickly.

"We are delighted by the progress of our clinical programme in diabetic neuropathy and by the reception it has received from the medical and scientific community," said Edward Lanphier, Sangamo's President and CEO.

"We believe our DNA-binding protein may provide a novel and much-needed therapeutic approach to diabetic neuropathy and optimistically look forward to the next stage of development of this novel therapeutic when phase-two clinical trials start later this year."

The incidence of diabetes, a condition in which the amount of glucose in the blood is too high, is increasing dramatically with the World Health Organisation estimating that some 300 million people worldwide could be affected by 2025.

The causes of diabetic neuropathy are not fully understood but researchers investigating the effect of glucose on nerves believe it is likely to be a combination of factors.


'"/>

Source:University of Manchester


Page: 1 2

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. NIAID Initiates Trial of Experimental Avian Flu Vaccine
3. Bird Brains Show How Trial and Error May Contribute to Learning
4. EuroVacc 02 HIV Vaccine Trial Begins
5. Visceral Leishmaniasis: Successful Vaccine Trial In Dogs
6. Trials for new drug to overcome HIV
7. New, automated tool successfully classifies and relates proteins in unprecedented way
8. Biomarkers isolated from saliva successfully predict oral and breast cancer
9. Secret of smallpoxs success may lead to bioterror cure
10. UN successfully tests green pesticide against locusts
11. Stem cell therapy successfully treats heart attack in animals
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Trial success for diabetic nerve therapy

(Date:6/18/2013)... at the University of Calgary,s Faculty of Medicine have ... body from harmful bacteria. Platelets, a component of blood ... for specific bacteria, and upon detection, seal it off ... were published in Nature Immunology this week, ... immunity. , "The science community has known that platelets ...
(Date:6/18/2013)... "dead zone" in the Gulf of Mexico and a ... this year, based on several NOAA-supported forecast models. , ... University, and the Louisiana Universities Marine Consortium are ... zone will be between 7,286 and 8,561 square miles ... That would range from an area the size of ...
(Date:6/18/2013)... MD, June 18, 2013: The Association for Molecular Pathology ... of American Societies for Experimental Biology (FASEB) on July ... membership on June 3, 2013. , The 26 ... and share a common vision for the advancement of ... biomedical and translational research is more important now than ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4
... 12 Industry Leaders Chosen for BOSS-UROCKVILLE, Md., Jan. 8 ... named Lockheed Martin (NYSE: LMT ) an industry ... Operations and Support Services - Unrestricted (BOSS-U) vehicle. As ... selected to participate in this indefinite delivery, indefinite quantity (ID/IQ) ...
... light-based probing techniques at the U.S. Department of Energy,s ... illuminated important details about a class of enzymes involved ... clocks. The interdisciplinary team has a broad ... 1930s and derive from riboflavin, or vitamin B2. These ...
... A group of Dartmouth researchers has found a ... chromosome segregation during cell division. Their finding adds to ... and contributes to understanding how cell function can go ... The researchers studied a protein called NOD, distantly related ...
Cached Biology News:Lockheed Martin Team Wins Role on Key Department of Defense Biometrics Contract Vehicle 2Researchers first to 'see' reactive oxygen species in vital enzyme 2Researchers first to 'see' reactive oxygen species in vital enzyme 3Dartmouth researchers find new protein function 2
(Date:6/18/2013)... June 18, 2013 The Regulatory ... of two new offices in Asia—one in Singapore and ... serve as RAPS’ Pan-Asia office , serving the ... more focused on audiences within China. , The announcement ... partnership with five Singapore government agencies to develop and ...
(Date:6/18/2013)... DuPont welcomes 48 of the nation’s ... National AgriScience Teachers Ambassador Academy this week (NATAA) at ... , The NATAA “Ag Academy” is a ... special project of the National FFA Foundation ... . The highly recommended agriscience teachers, who are ...
(Date:6/18/2013)... Delaware , June 18, 2013 ... announce the release of the HELM biomolecular representation ... open source MIT licence. HELM (Hierarchical ... a wide range of biomolecules (e.g. proteins, nucleotides, ... existing small-molecule and sequence-based informatics methodologies impractical or ...
(Date:6/18/2013)... , June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has ... Enforcement Administration (DEA) registration to handle Schedule 2 ... DEA,s acknowledgement of Burlington,s ... and documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
Breaking Biology Technology:RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2
... Percutaneous Systems, Inc.,(PercSys) announced today that it has ... Board of Directors. They include David Auth, Ph.D., ... Howard,Palefsky, a leading med-tech venture capitalist., "PercSys ... two of,the legendary figures of the medical device ...
... Offers Promising Patient Solutions, MARQUETTE, Mich., ... leader in innovative medical devices, announced today ... inter-body spacer. The,nanOss(TM)- Cervical cage is machined ... designed to function as bone.,The surgeries were ...
... in Third Quarter of 2008 Expands Worldwide ... Cutting-Edge Influenza Vaccine Technology, GAITHERSBURG, Md., Oct. ... its proprietary reverse genetics intellectual property,to Omninvest, a ... and construction of new vaccine strains to produce ...
Cached Biology Technology:PercSys Names David Auth and Howard Palefsky to Its Board of Directors 2Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device 2MedImmune Licenses Reverse Genetics Technology to Hungary's Omninvest for Use in Influenza Vaccine Development and Production 2
Request Info...
... The Gla-type Osteocalcin EIA Kit is ... kit for quantitative determination of human ... cell culture supernatants, and other biological ... research use only. It is not ...
Antibodies were affinity purified using epitopes specific to Alpha4 immobilized on solid support....
in vitro Translation, Accessory Products...
Biology Products: